Share
Publications
-
29 October 2004 /Prices and reimbursement
Consumption of strong analgesics (opioids) in the primary sector Denmark 1999-2003
The study describes the development of the use of strong analgesics (opiods incl. codeine) from 1999 to 2003 in the primary sector. The quantity consumption of opiods has increased by 25.1 per cent during this period from 18.6 DDD/1.000 inhabitants/day in 1999 to 23.2 DDD/1.000 inhabitants/day in 2003.
-
29 October 2004 /Prices and reimbursement
Development of benzodiazepine consumption in Denmark 1996-2003
The benzodiazepine consumption has declined over many years, and this development continues in 2003. During the 8-year study period, the consumption of benzodiazepines as sleeping medicine and sedatives halved from 30.8 to 15.4 DDD/1.000 inhabitants/day
-
17 August 2004 /Prices and reimbursement
Treatment of blood clots with platelet function inhibitors
The rising expenses of platelet function inhibitors are caused by several factors. In general, the consumption of these medicinal products is increasing, which is due to the fact that, both in relative and absolute terms, more people start treatment with platelet function inhibitors.
-
06 July 2004 /Prices and reimbursement
Sale of medicinal products for the treatment of erectile dysfunction
This study sheds light on the development of the use of medicinal products for the treatment of erectile dysfunction in the period between 1998 and 2003. In october 1998, Viagra® was put on the market, and since then the sale of medicinal products for the treatment of erectile dysfunction has increased rapidly.
-
11 June 2004 /Prices and reimbursement
Consumption of antidepressants in Denmark in the primary health sector in the period 1994-2003
Antidepressant is the designation for medicinal products for depression. At some point in life, approxiamtely 15 per cent of the Danish population will be diagnosed with depression (The Danish Medicinal Product catalogue 2003) - women twice as often as men.
